Why Attend
Love the skin you’re in? How about the bugs on it?
Over the six years we’ve run Microbiome Connect: Skin, the field has changed drastically. In a short period, the field has gone from fringe to mainstream, from quantifying the size of bacterial populations to understanding their function. As the field continues to commercialize, it is time to ask how this research can benefit consumers. How can the skin microbiome be leveraged as a source of biomarkers, as a therapeutic modality, as an understandable term to consumers?
Join us in Boston for a two-day face-to-face event, attended in the past by the likes of P&G, Jackson Laboratory, and the FDA. Unravel the function of the skin microbiome and apply the latest findings to your future products. See you in November!
Here’s a sneak peek of some key takeaways:
- Establish skin microbiome friendly hygiene products to meet consumer demands related to the pandemic, with Codex Beauty and Sanex
- Find out how to maintain regulatory standards and avoid litigation around claims with Q&A and presentations from FDA and NAD
- Discover how to use functional prebiotics to feed beneficial bacteria and increase product development price efficiency and convenience with Cybele Microbiome and Colgate Palmolive
- Tap into personalized skincare with pore specific Cutibacterium acnes data and analytics from Tami Lieberman and Dermala
- Leverage phage, LBP and autologous bactherapeutics to target skin disease with AOBiome, Azitra, Matrisys, BiomX and more
"This event is a unique gathering of individuals from academia and industry who are collaborating to advance microbiome science. Kisaco has gone out of their way to include speakers and perspectives not found elsewhere. I look forward to attending again" KC Communications Group
Advisory Board
Jay Tiesman
Dr. Jay Tiesman is a Principal Scientist in the Global Biotechnology Division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the Genomics Group Leader and a Corporate Technology Entrepreneur charged with helping to identify novel biotechnology innovations worldwide to address key needs for P&G. Since joining P&G in 1993, he has been actively involved in developing genomics capabilities within the Company. He has been particularly interested in the use of genomics to gain insight into epithelial cell biology.
Before joining P&G, he completed postdoctoral training in the laboratory of Dr. Charlie Hart at ZymoGenetics, Inc. in Seattle, Washington. At ZymoGenetics, he pursued research in the field of growth factor signal transduction associated with wound healing and tissue remodeling. He obtained his Ph.D. in Pathology from the University of Nebraska Medical Center in Omaha, Nebraska. In Omaha, he worked in the Laboratory of Dr. Angie Rizzino at the Eppley Cancer Institute, delineating the roles and impact of growth factors on embryonic development. Before joining Dr. Rizzino, he obtained Bachelor degrees in Philosophy and Biology at Creighton University in Omaha.
Dr. Tiesman was an early adopter of microarray technology, having worked in the field since 1997. He is an acknowledged microarray expert and has published over 35 articles, two of which have earned Publication of the Year honors. He also speaks extensively at international meetings on the topic of microarray experimental design and is listed on over 85 presentations. He collaborates extensively with scientists in academia and the biotechnology industry and is a member of several academic/governmental/industrial organizations, including the Association of Biomedical Resource Facilities Microarray Research Group (ABRF-MARG), the Association of Molecular Pathology (AMP), and the Society for Investigative Dermatology (SID); as well as the Scientific Advisory Board of NuGEN Technologies, Inc.
Sarah De Szalay
Larry Weis
Trevor Steyn
Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.
Ingmar Claes, PhD
Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.
In the context of YUN, he is closely working together with the Department of Bioscience Engineering of the University of Antwerp, the Lab of Applied Microbiology and Biotechnology of prof. Sarah Lebeer, the Lab of Pharmaceutical Technology and Biopharmacy of prof. Filip Kiekens, prof. dr. Julien Lambert (dermatology) and dr. Gilbert Donders (gynaecology, the University Hospital of Antwerp).
He has experience with leadership in multiple R&D projects and he held a managing role in YUN’s R&D projects of the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (VLAIO). YUN’s current range of probiotic products and therapies were developed under his supervision.
Dr Chris Callewaert
Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.
Audrey Gueniche Ph.D
Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials. Her passion is to always reinvent evaluation and find new fields of area in term of actives to promote.
She has published over 110 papers in peer-reviewed journals, 5 chapters in books, 2 specials issues in journal where she was the invited editor. She presented in over 80 international congresses and additionally she was personally invited to give more than 35 keynote lectures.
Erwan Peltier
Cath O’Neill
Who will be there
Meet Industry Leading Experts including:
- Independent Beauty Brands and Biotech Companies;
- Academic Researchers and Dermatologists;
- Multinational Beauty & Personal Care Brands and Multinational Pharmaceutical Companies;
- Cosmetic Formulators, Strain Manufacturers, Ingredients Suppliers, Packaging Manufacturers and Sequencing companies;
- Regulatory Experts and Consumer Trend Analysts; and
- Retailers and Distributors
Past attendees include:
HIGHLIGHTS FROM PREVIOUS MICROBIOME CONNECT: SKIN EVENTS
Speakers
Tami Lieberman
Tami Lieberman joined the MIT faculty in January 2018. She leads a computational and experimental research group focused on uncovering the principles governing colonization, niche range, and personalization in the human microbiome.
Tami trained in molecular biology and mathematics at Northwestern University, where she conducted research in the laboratory of Jon Widom and was funded by a Barry M. Goldwater Scholarship. She then earned a PhD in Systems Biology from Harvard University, where she conducted research in Roy Kishony’s laboratory. During her graduate research, Tami developed new genomic approaches for understanding how bacteria evolve during infections of individual people. As a postdoc in Eric Alm’s lab at MIT, she further developed and applied these genomic approaches to understand the microbes that colonize us during health. Tami has also made contributions to our understanding of antibiotic resistance, including the co-invention of a new platform for visualizing evolution in real time. Her work has been covered in the popular press, including online coverage from The Atlantic, The Wall Street Journal, National Geographic, The Boston Globe, and ArsTechnia.
Huiying Li
Larry Weiss
Greg Hillebrand
Barbara Paldus
Nicole Scott
Anahid Ugurlayan
Matthew Steele
Philippe Calais
Travis Whitfill
Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.
His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States.
Teruaki Nakatsuji
Søren Kjærulff
Rachel Behm
Assaf Oron
Steven Rosenfeld
Sarah De Szalay
Min Li
Lada Rasochova
Eric Clarke
Nicola Kingswell
Headline Partner
Colgate Palmolive
Website: https://www.colgatepalmolive.co.uk/
Please visit our website for more information.Platinum Event Partners
Bacthera
Website: https://www.bacthera.com/
Bacthera is a Danish/Swiss-based one-stop CDMO in the field of LBP’s, with the overall goal to enable the entire industry to further flourish by introducing industry changing innovations.
From small start-up’s to globally operating pharmaceutical companies, we support our clients developing analytical and manufacturing processes of their strains. With our long experience in handling bacteria in DS and DP production, we can offer tailor-made development and large-scale commercial solutions. Within our facilities, we can handle:
- Strictly and facultative anaerobes
- BSL1/2 categorized strains
- GMO’s
Our customers benefit from background technologies and GMP manufacturing know-how that originate from our mother companies Chr. Hansen & Lonza. In addition, Bacthera’s process expertise, enabling innovations and our world-class analytical services will contribute to our customer’s successful development of their LBP.
Diversigen
Website: https://diversigen.com/
Diversigen – Your Expert Source of Reliable Microbiome/Metagenomics Services and Insights
Leverage Diversigen’s CLIA/CAP-accredited microbiome profiling/bioinformatics services across the entire clinical research project lifecycle:
- Quality Leadership - Proven expertise, CLIA/CAP accredited
- Experienced - Pre-clinical studies, large clinical trials to single individual analysis
- Consultative/customized study support
- Breadth of services -16S/metagenomics (WGS)/qPCR development
- Flexible, agnostic bio-informatic pipelines/combined bio-statistical analysis
For more information, visit www.diversigen.com
Gold Event Partner
Biose Industrie
Website: https://www.biose.com/
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951, Biose Industrie has more than 65 years of experience in the development and production of live bacteria based drugs. Company offers lab development specialised in microbiology (anaerobic, aerobic, GMO strains) and is Drug GMP certified for the manufacturing of API (From 300L to 3 500L), clinical batches and commercial drug products (capsules in blisters or pills, sachets).
Silver Event Partners
Clinical Microbiomics
Website: www.clinical-microbiomics.com
Our inner ecology – that delicate microbial ecosystem known as the microbiome – is the new frontier in human health. At Clinical Microbiomics, we exist to untangle its complexity in search of mechanisms that impact health and disease.
Identifying and understanding those mechanisms is like looking for a needle in a haystack and demands a truly interdisciplinary approach to microbiome science. Innovating at the forefront of the field, our team of leading scientists creates breakthrough bioinformatics tools and analytical concepts that set new standards for understanding and influencing the microbiome.
Clinical Microbiomics is proud to partner with researchers from the world’s most prominent academic institutions and leading biotech, consumer health and pharma companies. Operating as an extension of their research organizations, we work broader, analyze deeper, and connect the dots to help find the answers needed to impact health and disease.
ReciBioPharm
Website: https://www.recipharm.com/about-us/bolstering-biologics
Please visit our website for more information.Metabolon
Metabolon deciphers thousands of discrete chemical signals from genetic and non-genetic factors to reveal biological pathways. We make connections where other ‘omics cannot, and provide the definitive representation of the phenotype.
Our work measures inputs from internal and external factors such as health, disease, nutrition, microbiome, medication, pollution, and more, to drive success in answering scientific questions about health and disease.
Every day, we accelerate research that leads to successes in biopharma, population health, consumer products, agriculture, wellness, and academic and government research sectors. This work has enabled modern science to gain a foothold in our understanding of complex disease, ultimately leading to the creation of new treatments that impact individuals and communities globally. Our scalable, customizable metabolomics solutions provide support across the research continuum from discovery through clinical trials, to in-market life cycle management.
LabSkin
Website: https://www.labskin.co.uk/
Labskin is a world-leading platform that has been producing lab-grown human skin for 15 years and using it to test cosmetic and skin health products for the world’s leading brands. Labskin is the only commercially available full thickness human skin model that naturally mimics the skin's microbiome.
In 2021, we launched Skin Trust Club which combined our deep science knowledge with our AI expertise in solving an unmet consumer need. Skin Trust Clun is a skin health tracking app that provides personalised skin care suggestions based on testing your unique skin microbiome.
CosmosID
Website: https://clinical-microbiomics.com/
CosmosID® provides end-to-end solutions unlocking the microbiome. A provider of CLIA-certified & ICH-GCP compliant NGS Services and Bioinformatics Solutions, CosmosID offers a range of validated and optimized workflows for research and development.
CosmosID also offers independently validated, industry-leading pipelines for processing metagenomic data, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision. Results can be accessed via CosmosID-HUB, a user-friendly and interactive software for comparative analysis of microbiome data, complete with dynamic charts, visualizations, and statistics.
Bronze Partner
Event Partners
Microba
Website: https://microba.com/
Microba is a global microbiome company including a precision microbiome analysis service division leveraging superior sampling method, high-throughput sequencing, best-in-class profiler, and the most comprehensive genome reference database.
Combined with advanced analytics, AI expertise and biological knowledge, Microba offers end-to-end research support with robust microbiome analysis and data interpretation, enabling therapeutic, diagnostic discoveries and exploratory microbiome monitoring. Using its platform, Microba’s ongoing population study also provides the largest catalogue of metagenome and associated metadata for data mining, and microbiome associations discovery.
Bristle
Bristle is a direct-to-consumer at-home oral health company. Bristle offers an at-home saliva test that analyzes the oral microbiome to assess a user's oral health status, then provides personalized coaching and recommendations to improve their health.
For more information, visit bristlehealth.com
Atlanta Clinical Trials
Atlantia Clinical trials is a world class provider of human clinical studies. For over a decade we have delivered clinical results to our many clients around the world, on time and on budget. We strive to offer the highest quality science while maintaining a cost-conscious approach to maximize the value proposition for each of our clients.
Our state-of-the-art ICH-GCP certified clinical sites in both Ireland (Cork) and the USA (Chicago) ensure we can offer multicenter, multinational studies of all design types, across a broad and diverse array of health areas and product portfolios.
Atlantia’s business model is different in that we are both the recruitment site AND the study conduction site in one company, which allows us to control the variables.
Some of our extensive clinical areas are healthy ageing, gastrointestinal function, sports performance, nutritional investigations, stress and cognitive health, cardiovascular health, metabolic health, immune function and microbiome dysbiosis of the gut, skin, and oral cavity.
Many of the studies we work on have been and are investigations of microbiome therapeutics and other active ingredients in both healthy and patient populations. These include LBT’s, prebiotic fibres, probiotics strains and a host of other products.
Millipore Sigma
Website: https://www.sigmaaldrich.com/US/en/products/molecular-biology-and-functional-genomics/microbiome
We are Merck KGaA, Darmstadt, Germany the vibrant science and technology company. Science is at the heart of everything we do, it drives the discoveries we make and the technologies we create.
Our products and services help you safely and efficiently develop and manufacture any therapies. We support everything from biologics to cell and gene therapies.
The latest offering is our microbiome platform. We offer microbiome products as well as one stop solution for microbiome multi-omics services: Metagenomics and Metabolomics services.
Our offering of microbiome workflow products and microbiome multi-omic services support researchers and therapy innovators in their pursuit to understand the microbiome. Our metagenomics services include Amplicon Sequencing (16S,18S, ITS) and Shotgun (WGS). Our metabolomics services include detection of Short chain fatty acids (SCFA), Bile acids and Amino acids (AA). Our unique M-CAMPTM cloud-based bioinformatic interactive platform provides users with an easy-to-use web interface to perform bioinformatic analysis on microbiome samples and download publication-ready graphics and reports.
B&D Nutritional Ingredients
Website: https://www.bdnutritional.com/
Please visit our website for more information.PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Download 2021 Agenda!
Love the skin you’re in? How about the bugs on it?
Join over 200+ key opinion leaders and 20+ expert speakers from the likes of MIT, UCLA and Amway Global Discovery. Microbiome Connect: Skin USA has dedicated content to translate the latest skin microbiome data and market analysis into beauty and personal care products.
Here’s a sneak peek of some key takeaways:
- Establish skin microbiome friendly hygiene products to meet consumer demands related to the pandemic, with Codex Beauty and Sanex
- Find out how to maintain regulatory standards and avoid litigation around claims with Q&A and presentations from FDA and NAD
- Discover how to use functional prebiotics to feed beneficial bacteria and increase product development price efficiency and convenience with Cybele Microbiome and Colgate Palmolive
- Tap into personalized skincare with pore specific Cutibacterium acnes data and analytics from Tami Lieberman and Dermala
- Leverage phage, LBP and autologous bactherapeutics to target skin disease with AOBiome, Azitra, Matrisys, BiomX and more
Download our Agenda
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
TICKET PRICE WILL INCREASE IN
— —
Venue
COURTYARD BY MARRIOTT, BOSTON DOWNTOWN BOUTIQUE HOTEL, 275 TREMONT STREET, BOSTON, MA 02116
Not sure where you stay? check out this hotel map, which marks all of the local hotels and prices just for you.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.